Medical
Endo Pharmaceuticals Launches Patient-Centric Campaign for Xiaflex
Endo Pharmaceuticals (OTCQX: NDOI) is shifting its marketing strategy for Xiaflex, the only FDA-approved nonsurgical treatment for Dupuytren’s contracture, with the launch of a new...
Breakthrough COVID-19 Vaccine Gains European Approval
In a significant development for the biotechnology industry, the European Commission has authorized the marketing of KOSTAIVE, the first self-amplifying mRNA (sa-mRNA) COVID-19 vaccine. This...
CSL Behring’s Hemophilia B Gene Therapy, HEMGENIX®, Shows Sustained Efficacy in Long-Term Study
CSL Behring (ASX: CSL, OTCQX: CSLLY) has released four-year data from its Phase 3 HOPE-B trial, demonstrating the long-term efficacy and safety of its gene...
Eli Lilly Fast-Tracks Retatrutide Data Release, Strengthening Position in Weight Loss Market
Eli Lilly (NYSE: LLY) has announced that data from a late-stage trial of its next-generation weight loss drug, retatrutide, is expected to be released later...
Orgenesis Receives Up to $5 Million Investment from Williamsburg Venture Holdings to Enhance CGT Platform
Orgenesis Inc. (OTCQX:ORGS), a global biotech company focused on advancing cell and gene therapies (CGT), has secured an equity investment of up to $5 million...
NanoViricides Partners with CRO to Advance Phase II Clinical Trials for NV-387
NanoViricides, Inc. (NYSE American: NNVC), based in Shelton, Connecticut, has announced a significant step in its clinical development pipeline by engaging a Clinical Research Organization...
Innovative Clinical Trial Utilizes Parsortix System to Advance Cancer Treatment
A recent clinical trial has unveiled promising data for a novel approach to cancer treatment, leveraging the Parsortix system to identify patients with highly metastatic...
Silo Pharma Strengthens Intellectual Property with New Provisional Patent for PTSD Treatment
Silo Pharma, Inc. (Nasdaq: SILO), a biopharmaceutical company focused on developing innovative therapeutics, has recently filed a provisional patent application with the U.S. Patent and...
CS Diagnostics Corp. Unveils MEDUSA with U.S. Launch of Innovative Disinfection Solution
CS Diagnostics Corp. (OTCQB: CSDX) has officially launched its innovative smart disinfectant product, MEDUSA, in the U.S. market. This next-generation disinfectant is engineered to elevate...
Kairos Pharma – A Business Update and Future Outlook
Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, has released an insightful update detailing its business progress and future objectives for 2025. The...
